NCT05150691 2026-01-28
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
Phase 1/2 Recruiting
DualityBio Inc.
European Organisation for Research and Treatment of Cancer - EORTC
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Hoffmann-La Roche